Company / Revenue
Progyny Revenue History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$1.3B
FY2025
5-year range
$500.6M / $1.3B
FY2021-FY2025
Trend
+10.4%
vs FY2024
Sector context
#94 of 150
Health Care
What the data says
At $1.3B, Progyny's revenue ranks #94 of 150 in the Health Care sector. Revenue has increased for 5 consecutive years, from $345M in FY2020 to $1.3B in FY2025.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +30.2%.
Improved from $1.1B to $1.3B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +17.9%
- 5-Year CAGR
- +30.2%
- 10-Year CAGR
- -
Sector benchmark
#94 of 150 in Health CareTop 63% of 150This company $1.3B Sector average $19.5B
▼
-93.4% below sector average
Key checks
Key Insights
- Progyny's revenue has grown for 5 consecutive years.
- 5-year CAGR of +30.2%, indicating consistent growth.
- In FY2025, revenue increased 10.4% year-over-year.
- Ranks #94 out of 150 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +10.4% |
| FY2024 | $1.2B | +7.2% |
| FY2023 | $1.1B | +38.3% |
| FY2022 | $786.9M | +57.2% |
| FY2021 | $500.6M | +45.2% |
| FY2020 | $344.9M | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026